Digital Evidence Base

Trusted Knowledge for Informed Decisions

Filters
SDGs
Priority Areas
Research Outcomes
Document Type
Year
4019 results found
Show:
"Has the patient been coughing?" Do Ugandan providers ask patients tested for malaria about cough history? Secondary analysis of 2011 data from the Integrated Infectious Disease Capacity Building Evaluation (IDCAP)
Henry Ashley
2015

Introduction: In 2013, malaria caused an estimated 584,000 deaths worldwide, with 90% of those deaths occurring in Africa. The Integrated Management of Childhood Illness (IMCI) strategies have been effective at …

Abstract
Multivitamin supplementation in HIV infected adults initiating antiretroviral therapy in Uganda: the protocol for a randomized double blinded placebo controlled efficacy trial
Guwatudde D, Spiegelman D, Wabwire-Mangen F, Ezeamama AE, Bagenda D, Kyeyune R, Wamani H, Mugusi F, Wang ML, Manabe YC, Fawzi WW
2012
DOI: 10.1186/1471-2334-12-304

Background: Use of multivitamin supplements during the pre-HAART era has been found to reduce viral load, enhance immune response, and generally improve clinical outcomes among HIV-infected adults. However, immune reconstitution …

Abstract
The Experiences of AIDS Orphans Living in a Township
Frood Sharron, Ricks Esmeralda, Rooyen Dalena Van
2012

An overwhelming challenge to health-care professionals today; is the rendering of care services to AIDS orphans. This article is based on a study that explored and described the lived experiences …

Abstract
Evaluation du succès implantaire chez les patients avec antécédents de maladies parodontales: revue systématique
Guirassy Mouhamadou Lamine, Kane Aboubacar Sidiki Thissé, Diarra Abdouaziz, Mobio Gnaba Samson, Boussehain Mariam, Benoist Henri Michel
2020

INTRODUCTION: Une série de facteurs de risque a été reliée au développement de la maladie péri-implantaire, parmi lesquels: la mauvaise hygiène orale, le diabète, le tabagisme et l'antécédent de parodontites. …

Abstract
Associations between low HDL, sex and cardiovascular risk markers are substantially different in sub-Saharan Africa and the UK: analysis of four population studies
Asiki G, Newton R, Greiner R, Nyrienda M, Rodgers L, Banda L, Shields B, Hattersley A, Crampin A, Jones A
2021
DOI: 10.1136/bmjgh-2021-005222

Introduction Low high-density lipoprotein (HDL) is widely used as a marker of cardiovascular disease risk, although this relationship is not causal and is likely mediated through associations with other risk …

Abstract
Association between crural vessel patency and successful transmetatarsal amputation: a single centre experience
Kamali Dariush, Thomas Matthew, Loo Peter Van, Nichol Ian
2018

Background:Transmetatarsal amputation (TMA) has a reputation for failure, centred around wound breakdown. No study has looked at the direct association between the patency of individual crural arteries and the healing …

Abstract
Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis
Giugliano Robert P., Pedersen Terje R., Saver Jeffrey L., Sever Peter S., Keech Anthony C., Bohula Erin A., Murphy Sabina A., Wasserman Scott M., Honarpour Narimon, Wang Huei, Lira Pineda Armando, Sabatine Marc S.
2020
DOI: 10.1161/STROKEAHA.119.027759

Background and Purpose- The PCSK9 (proprotein convertase subtilisin-kexin type 9) monoclonal antibody evolocumab lowered LDL (low-density lipoprotein) cholesterol by 59% to 0.8 (0.5-1.2) mmol/L and significantly reduced major vascular events …

Abstract
The Role of Anxiety Sensitivity in Treatment Outcomes for Patients with Post-Traumatic Stress Disorder in a Collaborative Care Intervention
Harrison Austin Reed
2021

Most contemporary PTSD models posit that cognitive factors, such as beliefs about oneâs symptoms, are integrally involved in the onset, maintenance, and severity of PTSD symptoms. Of the relevant cognitive …

Abstract
Apabetalone downregulates fibrotic, inflammatory and calcific processes in renal mesangial cells which may contribute to reduced cardiac events observed in ckd patients
Gilham D., Fu L., Rakai B., Wasiak S., Tsujikawa L., Halliday C., Sarsons C., Stotz S., Jahagirdar R., Johansson J., Sweeney M., Wong N., Kalantar-Zadeh K., Kulikowski E.
2021
DOI: 10.1093/ndt/gfab078.008

BACKGROUND AND AIMS: Major adverse cardiac events (MACE) remain a leading cause of mortality in chronic kidney disease (CKD). Apabetalone is an orally available inhibitor of bromodomain & extraterminal (BET) …

Abstract
AI Research Assistant
AI-powered research assistance. Uses the Digital Evidence Base as the Knowledge source.